As EGFR is one of the key factors in promoting ovarian cancer cell growth (Alper et al, 2000, 2001; Pack et al, 2004), our results also suggest an alternative target to suppress EGFR signalling pathway through inactivation of Id-1, thus inhibiting cancer cell growth. This evidence concerns the gene EGFR and ovarian carcinoma.